PreveCeutical Medical Inc. announced that on April 21, 2023, PreveCeutical created a new division to develop and train an Artificial Intelligence (AI) tool that will be capable of learning R&D, clinical trials, and other clinical information. PreveCeutical plans to use this tool in the development and process of all clinical programs. This should enhance, accelerate and predict outcomes, processes and solutions, amongst other selected data. In preparation, the company have purchased the domain, which will be developed over the coming weeks to provide information on the AI program and development.